Copy Link Print Information

Atorvastatin sodium

67 Cited Publications
Kundenbewertung

Based on 67 publication(s) in Google Scholar

Atorvastatin sodium is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin sodium inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.85%
  • CAS. Nr.: 134523-01-6
  • Formel: C33H34FN2NaO5
  • Molecular Weight:580.62
  • Speicherung:

    Store at room temperature, keep dry and cool.

    In solvent   -80°C, 1 year , -20°C, 6 months
  • Atorvastatin sodium Chemical Structure
    Atorvastatin sodium Chemical Structure
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
  • Experimental Validation Results for Atorvastatin sodium
CAS. Nr.: 134523-01-6
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Atorvastatin sodium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Atorvastatin sodium

More
Customer Validation & Images
In Vivo Efficacy StudyFlow CytometryELISAHistological Imaging/StainingIFWBBio/Physico-chemical AssayCell Proliferation/Viability Assay
  • Flow Cytometry
  • ELISA
  • In Vivo Efficacy Study
  • WB
  • Histological Imaging/Staining
  • WB
  • Bio/Physico-chemical Assay
  • WB
  • WB
  • Cell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • IF
Keywords
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Atorvastatin sodium Chemical Structure
    Atorvastatin sodium Chemical Structure
    1/16
  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Oct;7(10):2142-2164. [Abstract]

    Customer Validation
     Representative histogram and quantification of normalized MHC I membrane levels determined by flow cytometry (stained for anti-HLA-A, anti-HLA-B and anti-HLA-C) in response to indicated treatment conditions in iAstrocytes (N = 4–6; three (control and cholesterol) or two (Atorvastatin hemicalcium salt) independent experiments from two isogenic sets. Data are shown as the mean. *P < 0.05 (two-sided one-sample t-test for cholesterol and atorvastatin versus 1).

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Oct;7(10):2142-2164. [Abstract]

    Customer Validation
     Secreted Il-6 levels in medium of ApoE3 iAstrocytes that were pretreated with or without exogenous Cholesterol (10 μM) or Atorvastatin hemicalcium salt (0.5 μM) for 1 h before 24-h cotreatment with increasing doses of TNF, IL-1α and C1q.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2025 Oct:146:157128. [Abstract]

    Customer Validation
     ApoE-/- mice were administrated with high-fat-diet accompanied by MFEVLPs (5 or 50 μg/d, i.p) or Atorvastatin (10 mg/kg/day, i.g) for 12 weeks.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Environ Sci Technol Lett. 2025 Apr 8.

    Customer Validation
     The hCMEC-D3 cells were exposed to 0.01 μM 77PD-Q for 24 h in the presence or absence of 0.3 μM Atorvastatin (0.3 μM, 24 h).

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jul 5:e2403451. [Abstract]

    Customer Validation
     Representative images of p-AKT1 staining of liver sections of the DMSO, Simvastatin and Atorvastatin hemicalcium salt (20 mg/kg, 3 days, atorvastatin with HFD)‐treated mice.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jul 5:e2403451. [Abstract]

    Customer Validation
     Western blotting of PAQR9 in mouse primary hepatocytes under the treatment of DMSO, Simvastatin (Sim), Atorvastatin hemicalcium salt (Ator, 10 mmol/L, 24-48 h) and Rosuvastatin (Rosu).

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jul 5:e2403451. [Abstract]

    Customer Validation
     The top 20 predicted transcription factors of differentially expressed genes under Atorvastatin hemicalcium salt treatment. The gene expression data were from GEO datasets GSE24188 and the TF prediction was by ChEA3. The bar showed rank score and the line showed the number of overlapped genes.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Dec 25;8(1):457. [Abstract]

    Customer Validation
     EGFRvIII-high U87 cells were cocultured with EGFRvIII-CAR-T cells and treated with Atorvastatin (5 μM, 3 days) or Cytochalasin D (10 μg/mL, 1 day). Immunoblotting of magnetically separated cells showed that both drugs alleviated CAR molecule transfer (representative of three independent experiments).

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2023 Jan 1:552:215976. [Abstract]

    Customer Validation
     Panc-1 and MIA PaCa-2 cells were treated with Atorvastatin (20 μM or 50 μM) for 24 h. FOXM1 and mutant p53 protein levels were measured in different treatment groups.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Oncogene. 2022 Dec;41(49):5266-5278. [Abstract]

    Customer Validation
     ATP assay. The combination of Atorvastatin (2.5, 5, 10, 20 μM; 48 h) and SR1078 synergistically inhibits CRC cell viability.

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. [Abstract]

    Customer Validation
     Tumor volumes of indicated patient-derived xenografts (PDXs) treated with Atorvastatin (40 mg/kg, i.p., every two days for 30 days).

  • 1/16

    Atorvastatin sodium purchased from MedChemExpress. Usage Cited in: Endocrinology. 2018 May 1;159(5):2008-2021. [Abstract]

    Customer Validation
     Male C57BL/6 mice are intragastrically treated with Atorvastatin (0.1 mg/kg/day) and placebo for 10 weeks in the presence of HFD after 10-week-HFD feeding and then sacrificed for sample collection. H&E and oil red O staining of frozen liver sections.

  • Atorvastatin sodium